Pharmacovigilance and Public Health

The objective of this research group is to investigate drug safety, adverse drug reactions (ADRs), and the burden of disease across diverse populations. The group also explores the prevalence of various diseases, their socioeconomic determinants, and the treatment challenges faced by patients in resource-limited settings. By analyzing drug utilization patterns and identifying risk factors associated with adverse outcomes, the team generates critical insights that inform public health policies and enhance clinical practice. Additionally, the group’s research outputs help increase awareness of pharmacovigilance systems among healthcare professionals and students, thereby fostering a culture of patient safety and evidence-based decision-making in healthcare systems.

INTEREST(S)

-

MODERATOR

VISION

The vision of this Research Group is to become a leading national and regional center for excellence in drug safety and public health research. The group envisions fostering a robust culture of pharmacovigilance and evidence-based healthcare decision-making among professionals, policymakers, and students. Through impactful research, education, and collaboration, the group aspires to contribute to the development of safer healthcare systems, improved therapeutic outcomes, and the advancement of public health initiatives in Bangladesh and beyond.

MISSION

The mission of this Research Group is to promote the safe and effective use of medicines through systematic monitoring, evaluation, and reporting of drug-related problems. The group is dedicated to investigating adverse drug reactions (ADRs), drug utilization patterns, and the socioeconomic determinants of health to improve treatment outcomes and reduce the burden of disease. By integrating pharmacovigilance with public health research, the team aims to generate evidence that informs clinical practice, strengthens healthcare systems, and enhances patient safety in both urban and resource-limited settings.

MEMBER(S)